Investor Type | Firm |
Industries | BioTech • CleanTech • A.I. (& Big Data) • Material Science • DeepTech |
Stages | Seed, Pre-seed |
Investing | United Kingdom |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Zero Carbon Capital (ZCC) is an investment fund focused on supporting early-stage European companies developing groundbreaking technologies in sectors poised to significantly reduce carbon emissions. With deep scientific innovation and market dynamics acting as driving forces, ZCC targets industries including BioTech, CleanTech, A.I. (& Big Data), Material Science, and DeepTech. They aim to catalyze the transition to a net-zero economy by investing in solutions with the potential to remove at least 0.5 Gt CO2e per year. Committed to tackling the hard problems of decarbonization, ZCC seeks out exceptional founders working on transformative solutions. Their investment parameters range from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot of around $1,500,000 for seed and pre-seed stages. As 'first money' investors, ZCC leverages their expertise in science and engineering, combined with their experience in technology, innovation, and business, to support the commercialization of scientific breakthroughs. This is underpinned by a team with a history of working on influential products and the readiness to impart business acumen to nascent climate tech startups. They provide not just funding but also strategic assistance to help scientist-entrepreneurs overcome initial hurdles, accelerate their progress, and achieve substantial growth. Emphasizing the need for a diversified portfolio to mitigate risks, ZCC collaborates with Sapphire Capital Partners LLP as their fund manager for investment processes. They work closely with a network of advisors and investors to confront the challenges faced by portfolio companies, ensuring sustained support and connectivity with late-stage investors. Zero Carbon Capital practices a hands-on approach and is actively involved in the developmental journey of their portfolio companies, from lab to market. Aware of the risks associated with investing in startups and early-stage companies, they advocate for investor education on such risks including illiquidity, lack of dividends, and potential loss of investment.